SECsense Logo

Meihua International Medical Technologies 6-K Report: Key Financial Insights

$MHUA
Form 6-K
Filed on: 2025-01-03
Source
Meihua International Medical Technologies 6-K Report: Key Financial Insights

Here are the key insights extracted from the financial report of Meihua International Medical Technologies Co., Ltd., as detailed in the 6-K SEC filing:

  1. Company Overview:
  • Name: Meihua International Medical Technologies Co., Ltd.
  • Incorporation: Cayman Islands
  • Address: 88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, 225000, People's Republic of China.
  1. Filing Details:
  • Form Type: 6-K
  • Commission File Number: 001-41291
  • Report Date: January 3, 2025 (covering the month of January 2025).
  1. Securities Purchase Agreement:
  • The company entered into an amendment to the existing securities purchase agreement (SPA) dated December 27, 2023, with Anson Investments Master Fund LP and Anson East Master Fund LP.
  • The original SPA was for the sale of up to $50.5 million in convertible notes and warrants.
  1. Amendment Details:
  • Effective Date: December 26, 2024.
  • The Amendment stipulates that only a single closing of $6,000,000 will occur under the SPA, which was completed on January 2, 2024.
  • No further closings will take place under this agreement.
  1. Exhibits:
  • The Amendment to the SPA is attached as Exhibit 10.1 and is incorporated by reference into the report.
  1. Signatures:
  • The report is signed by Xin Wang, who holds the title of Chief Executive Officer and is identified as the Principal Executive Officer of the company.

This summary captures the essential elements of the financial report, including corporate details, significant financial transactions, and governance indications.